Astex

News

Roche looks to Astex in $515m breast cancer deal

Roche's Genentech unit has forged an alliance with Astex, worth up to $515m, to partner on a fragment-based drug discovery programme in breast cancer.

News

Three more pharmas join OpenFold3 AI consortium

Bristol Myers Squibb, Takeda, and Astex have joined a consortium working on refining the OpenFold structure prediction platform with industry data.

News

Merck & Co joins KRAS gold rush with Taiho and Astex collabo...

US-based Merck & Co has forged an R&D tie-up with Taiho and Astex Pharmaceuticals, focused on developing small molecule drugs targeting the KRAS gene that has become the subject of

News

UK biotech Astex celebrates as Novartis breast cancer drug a...

Cambridge firm played key role in discovery of potential blockbuster Kisqali.

Roche looks to Astex in $515m breast cancer deal

Three more pharmas join OpenFold3 AI consortium

Merck & Co joins KRAS gold rush with Taiho and Astex collabo...

UK biotech Astex celebrates as Novartis breast cancer drug a...

Closing the global evidence gap in oncology, with Flatiron H...

Securing your ROI: Turning post-acquisition integration into...

Astex

Editor's Picks